X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
abridged index medicus (11) 11
humans (10) 10
male (9) 9
middle aged (9) 9
aged (8) 8
cardiovascular disease (8) 8
female (8) 8
medicine, general & internal (8) 8
mortality (8) 8
analysis (7) 7
cardiovascular diseases (7) 7
health risk assessment (7) 7
studies (7) 7
adult (6) 6
epidemiology (6) 6
hypertension (6) 6
internal medicine (6) 6
stroke (6) 6
clinical medicine (5) 5
developed countries (5) 5
developing countries (5) 5
klinisk medicin (5) 5
risk factors (5) 5
blood pressure (4) 4
canada (4) 4
low income groups (4) 4
prospective studies (4) 4
risk (4) 4
blood-pressure (3) 3
cardiovascular diseases - mortality (3) 3
case-control studies (3) 3
china (3) 3
health aspects (3) 3
hypertension - complications (3) 3
income (3) 3
low-income countries (3) 3
prevention (3) 3
urine (3) 3
acute coronary syndromes (2) 2
adrenergic beta-antagonists - therapeutic use (2) 2
angiotensin-converting enzyme inhibitors - therapeutic use (2) 2
antihypertensive agents - therapeutic use (2) 2
association (2) 2
atrial fibrillation - complications (2) 2
brain ischemia - complications (2) 2
cardiac and cardiovascular systems (2) 2
cardiovascular agents - therapeutic use (2) 2
cardiovascular diseases - epidemiology (2) 2
cardiovascular diseases - etiology (2) 2
cardiovascular diseases - prevention & control (2) 2
cardiovascular-disease (2) 2
cerebral hemorrhage - complications (2) 2
clinical outcomes (2) 2
clustering (2) 2
communities (2) 2
community (2) 2
consumption (2) 2
data collection (2) 2
diet (2) 2
evidence-based medicine (2) 2
fruits (2) 2
general & internal medicine (2) 2
global health (2) 2
health care (2) 2
health risks (2) 2
heart (2) 2
heart attacks (2) 2
heart-failure (2) 2
hospitals (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2) 2
india (2) 2
kardiologi (2) 2
long-term care (2) 2
malaysia (2) 2
medical research (2) 2
medical services (2) 2
mercury (2) 2
myocardial infarction (2) 2
myocardial-infarction (2) 2
pakistan (2) 2
platelet aggregation inhibitors - therapeutic use (2) 2
potassium excretion (2) 2
preventive medicine (2) 2
reduction (2) 2
risk-factors (2) 2
rural population (2) 2
secondary prevention (2) 2
socioeconomic factors (2) 2
sodium (2) 2
sodium - urine (2) 2
sodium, dietary - administration & dosage (2) 2
south africa (2) 2
stroke - epidemiology (2) 2
stroke - etiology (2) 2
treatment outcome (2) 2
urban population (2) 2
waist-hip ratio (2) 2
0 (1) 1
accidental falls (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by O'Donnell, Martin J, Dr and Chin, Siu Lim and Rangarajan, Sumathy, MSc and Xavier, Denis, Prof and Liu, Lisheng, Prof and Zhang, Hongye, Prof and Rao-Melacini, Purnima, MSc and Zhang, Xiaohe, MSc and Pais, Prem, Prof and Agapay, Steven, BSc and Lopez-Jaramillo, Patricio, Prof and Damasceno, Albertino, MD and Langhorne, Peter, Prof and McQueen, Matthew J, Prof and Rosengren, Annika, Prof and Dehghan, Mahshid, PhD and Hankey, Graeme J, Prof and Dans, Antonio L, Prof and Elsayed, Ahmed, Prof and Avezum, Alvaro, Prof and Mondo, Charles, Prof and Diener, Hans-Christoph, Prof and Ryglewicz, Danuta, Prof and Czlonkowska, Anna, Prof and Pogosova, Nana, Prof and Weimar, Christian, Prof and Iqbal, Romaina, PhD and Diaz, Rafael, Prof and Yusoff, Khalid, Prof and Yusufali, Afzalhussein, Prof and Oguz, Aytekin, Prof and Wang, Xingyu, Prof and Penaherrera, Ernesto, MD and Lanas, Fernando, Prof and Ogah, Okechukwu S, MD and Ogunniyi, Adesola, Prof and Iversen, Helle K, MD and Malaga, German, Prof and Rumboldt, Zvonko, Prof and Oveisgharan, Shahram, Prof and Al Hussain, Fawaz, MD and Magazi, Daliwonga, MD and Nilanont, Yongchai, MD and Ferguson, John, PhD and Pare, Guillaume, MD and Yusuf, Salim, Prof and INTERSTROKE Investigators and INTERSTROKE investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10046, pp. 761 - 775
Summary Background Stroke is a leading cause of death and disability, especially in low-income and middle-income countries. We sought to quantify the... 
Internal Medicine | ETHNIC-DIFFERENCES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | CARDIOVASCULAR-DISEASE | ALCOHOL-CONSUMPTION | DIETARY PATTERNS | ISCHEMIC-STROKE | BURDEN | HEMORRHAGIC STROKE | BLOOD-PRESSURE | ATRIAL-FIBRILLATION | Humans | Middle Aged | Male | Apolipoproteins B - blood | Motor Activity | Cerebral Hemorrhage - blood | Hypertension - blood | Stroke - pathology | Brain Ischemia - blood | Obesity, Abdominal - epidemiology | Odds Ratio | Waist-Hip Ratio | Brain Ischemia - complications | Brain Ischemia - epidemiology | Risk Factors | Self Report | Atrial Fibrillation - complications | International Cooperation | Biomarkers - blood | Evidence-Based Medicine | Health Behavior | Stroke - etiology | Obesity, Abdominal - complications | Cerebral Hemorrhage - complications | Smoking - adverse effects | Africa - epidemiology | Case-Control Studies | Diabetes Complications - epidemiology | Adult | Female | Stroke - epidemiology | Hypertension - epidemiology | Diabetes Complications - prevention & control | Stroke - prevention & control | Risk Reduction Behavior | Europe - epidemiology | Feeding Behavior | China - epidemiology | Alcohol Drinking - adverse effects | Australia - epidemiology | Stroke - blood | Middle East - epidemiology | Asia - epidemiology | Atrial Fibrillation - epidemiology | Cerebral Hemorrhage - epidemiology | Alcohol Drinking - epidemiology | Smoking - epidemiology | Hypertension - complications | Aged | Apolipoprotein A-I - blood | Stroke (Disease) | Risk factors | Studies | Pathology | Stroke | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9735, pp. 112 - 123
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 465 - 475
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9990, pp. 266 - 273
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10013, pp. 61 - 69
Summary Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible... 
Internal Medicine | Drug Costs | Platelet Aggregation Inhibitors - economics | Cardiovascular Diseases - drug therapy | Humans | Income | Malaysia | Secondary Prevention | Aspirin - supply & distribution | Urban Population | Angiotensin-Converting Enzyme Inhibitors - supply & distribution | Angiotensin-Converting Enzyme Inhibitors - economics | Sweden | Pakistan | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iran | Rural Population | China | Adrenergic beta-Antagonists - economics | Brazil | Poland | Aspirin - therapeutic use | Aspirin - economics | Chile | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Agents - economics | Colombia | Argentina | Platelet Aggregation Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | United Arab Emirates | Adrenergic beta-Antagonists - supply & distribution | India | Pharmacies | Canada | Cardiovascular Agents - supply & distribution | Cardiovascular Agents - therapeutic use | Bangladesh | Family Characteristics | Developed Countries | Turkey | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | South Africa | Zimbabwe | Developing Countries | Drugs | Prevention | Usage | Cardiovascular diseases | Analysis | Disease prevention | Cardiovascular disease | Costs | Health care access | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article